Paper Details

  1. Home
  2. Paper Details

Development of oral immunomodulatory agents in the management of multiple sclerosis.

Author: AlsanousiAli, FriedeTim, GiannettiPaolo, MuraroPaolo A, NicholasRichard

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Five oral therapies for multiple sclerosis (MS) are now available: cladribine, fingolimod, laquinimod, BG-12, and teriflunomide. These therapies are more convenient than injectable therapies, but they also have side effects.
Paper Details　
Original Abstract of the Article :
The emergence of oral disease-modifying therapies in multiple sclerosis (MS) will have a significant impact on the evolving scenario of immunomodulatory treatments in MS where current therapies are all injectable. Reducing relapses in trials translates for individuals with MS into a therapeutic aim ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100222/

データ提供：米国国立医学図書館（NLM）

Oral Immunomodulatory Agents: A New Era for Multiple Sclerosis Treatment

The quest for effective and convenient treatments for [multiple sclerosis (MS)] is like a never-ending journey across a vast and complex desert, seeking to conquer this debilitating disease. This research explores the development of [oral immunomodulatory agents] for MS, focusing on the potential for these therapies to improve treatment outcomes and enhance patient quality of life. The authors discuss the emergence of several new oral therapies for MS and their implications for the evolving landscape of MS treatment.

Oral Therapies: A New Frontier in MS Treatment

The authors highlight the significant impact of oral therapies on the treatment of MS, offering greater convenience and accessibility for patients compared to injectable therapies. They discuss the potential benefits of these therapies in reducing relapses and slowing disease progression, while also addressing concerns regarding side effects and long-term safety. The emergence of oral therapies represents a significant step forward in the fight against MS, offering new hope for patients and their families.

Navigating the Complexities of MS Treatment

This research emphasizes the importance of ongoing research and innovation in the field of MS treatment, seeking to develop more effective and well-tolerated therapies. The authors encourage healthcare providers to stay abreast of the latest advancements in MS treatment and to consider the potential benefits of oral therapies for their patients. It is crucial to consult with a healthcare professional to discuss the best treatment plan for your individual needs and to understand the benefits and risks associated with different therapies.

Dr.Camel's Conclusion

This research is like a beacon of hope in the desert of MS treatment, illuminating the path toward a future where patients have access to effective and convenient therapies. The emergence of oral immunomodulatory agents represents a significant step forward in the fight against MS, offering new hope for patients and their families. The authors' work is a testament to the ongoing dedication of researchers and clinicians worldwide who are committed to improving the lives of those affected by MS.

Date :
  1. Date Completed 2011-09-16
  2. Date Revised 2023-11-05
Further Info :

Pubmed ID

21625416

DOI: Digital Object Identifier

PMC3100222

Related Literature

Article Analysis
・Effects of cladribine injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.